» Articles » PMID: 20938050

Grainyhead-like 2 Enhances the Human Telomerase Reverse Transcriptase Gene Expression by Inhibiting DNA Methylation at the 5'-CpG Island in Normal Human Keratinocytes

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 Oct 13
PMID 20938050
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

We recently identified Grainyhead-like 2 (GRHL2) as a novel transcription factor that binds to and regulates the activity of the human telomerase reverse transcriptase (hTERT) gene promoter. In this study, we investigated the biological functions of GRHL2 and the molecular mechanism underlying hTERT gene regulation by GRHL2. Retroviral transduction of GRHL2 in normal human keratinocytes (NHK) led to a significant extension of replicative life span, whereas GRHL2 knockdown notably repressed telomerase activity and cell proliferation. Using promoter magnetic precipitation coupled with Western blotting, we confirmed the binding of GRHL2 to the hTERT promoter and mapped the minimal binding region at -53 to -13 of the promoter. Furthermore, mutation analysis revealed the three nucleotides from -21 to -19 to be critical for GRHL2 binding. Because hTERT expression is regulated in part by DNA methylation, we determined the effects of GRHL2 on the methylation status of the hTERT promoter. Senescent NHK exhibited hypermethylation of the CpG island, which occurred with the loss of hTERT expression. On the contrary, the promoter remained hypomethylated in GRHL2-transduced NHK, irrespective of cell proliferation status. Also, knockdown of endogenous GRHL2 led to hypermethylation of the promoter. These results indicate that GRHL2 regulates the hTERT expression through an epigenetic mechanism and controls the cellular life span.

Citing Articles

GRHL2 regulates keratinocyte EMT-MET dynamics and scar formation during cutaneous wound healing.

Chen T, Zhang B, Xie H, Huang C, Wu Q Cell Death Dis. 2024; 15(10):748.

PMID: 39402063 PMC: 11473813. DOI: 10.1038/s41419-024-07121-7.


The evolving genetic landscape of telomere biology disorder dyskeratosis congenita.

Tummala H, Walne A, Badat M, Patel M, Walne A, Alnajar J EMBO Mol Med. 2024; 16(10):2560-2582.

PMID: 39198715 PMC: 11473520. DOI: 10.1038/s44321-024-00118-x.


Grainyhead-like-2, an epithelial master programmer, promotes interferon induction and suppresses breast cancer recurrence.

MacFawn I, Farris J, Pifer P, Margaryan N, Akhter H, Wang L Mol Immunol. 2024; 170:156-169.

PMID: 38692097 PMC: 11106721. DOI: 10.1016/j.molimm.2024.04.012.


Grainyhead-like 2 is required for morphological integrity of mouse embryonic stem cells and orderly formation of inner ear-like organoids.

Forrester-Gauntlett B, Peters L, Oback B Front Cell Dev Biol. 2023; 11:1112069.

PMID: 37745294 PMC: 10513505. DOI: 10.3389/fcell.2023.1112069.


hPSC-derived sacral neural crest enables rescue in a severe model of Hirschsprung's disease.

Fan Y, Hackland J, Baggiolini A, Hung L, Zhao H, Zumbo P Cell Stem Cell. 2023; 30(3):264-282.e9.

PMID: 36868194 PMC: 10034921. DOI: 10.1016/j.stem.2023.02.003.


References
1.
Mace K, Pearson J, McGinnis W . An epidermal barrier wound repair pathway in Drosophila is mediated by grainy head. Science. 2005; 308(5720):381-5. DOI: 10.1126/science.1107573. View

2.
Lo Y, Wong I, Zhang J, Tein M, Ng M, Hjelm N . Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res. 1999; 59(16):3899-903. View

3.
Kim N, Piatyszek M, Prowse K, Harley C, WEST M, Ho P . Specific association of human telomerase activity with immortal cells and cancer. Science. 1994; 266(5193):2011-5. DOI: 10.1126/science.7605428. View

4.
Svedruzic Z . Mammalian cytosine DNA methyltransferase Dnmt1: enzymatic mechanism, novel mechanism-based inhibitors, and RNA-directed DNA methylation. Curr Med Chem. 2008; 15(1):92-106. DOI: 10.2174/092986708783330700. View

5.
Wooten L, Ogretmen B . Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide. J Biol Chem. 2005; 280(32):28867-76. DOI: 10.1074/jbc.M413444200. View